RxDoctor Payments Data

Charles Webb, MD

Allergy · Boise, IDNPI 1609865880

Payments from drug & device makers

$5,917in general payments, 2019–2025

Across 325 payments — averaging $18.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$1K
  • GSK$856
  • Grifols USA, LLC$699
  • Regeneron Healthcare Solutions, Inc.$434
  • Takeda Pharmaceuticals U.S.A., Inc.$381
  • Blueprint Medicines Corporation$228
  • plus $2K from 23 others

What the payments were for

  • Consulting fees$972%
  • Food & beverage$5,79998%
  • Education$210%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

Too few allergy providers in Idahoto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$181,865
Medicare patients
165
Services billed
9,287

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
NucalaMepolizumab30$218,385
XolairOmalizumab60$202,731
Dupixent SyringeDupilumab13$48,356
Trelegy ElliptaFluticasone/Umeclidin/Vilanter35$45,931
Breztri AerosphereBudesonide/Glycopyr/Formoterol31$23,588
Breo ElliptaFluticasone/Vilanterol38$17,610
Epinephrine39$9,566
SymbicortBudesonide/Formoterol Fumarate23$5,393
Cromolyn Sodium16$4,623
Azelastine Hcl174$3,852
Arnuity ElliptaFluticasone Furoate14$2,903
Albuterol Sulfate HfaAlbuterol Sulfate87$2,020
Ipratropium Bromide83$1,890
Fluticasone-SalmeterolFluticasone Propion/Salmeterol19$1,701
Fluticasone Propionate45$769

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKNucala, Trelegy Ellipta, Breo Ellipta, Arnuity Ellipta$856$284,829117 claims
AstraZenecaBreztri Aerosphere, Symbicort$1,417$28,98154 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few allergy providers in Idahoon file to place this against a meaningful peer group, so we don't.

Other allergy in Boise

Where these figures come from

Is this you, or does something look wrong? →